• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病和糖尿病患者的最新管理方法。

Updated management for patients with cardiovascular disease and diabetes.

作者信息

Dugan Joy, Butts Amy, Collins Billy St John, Saini Parmjeet S, Bradley Sarah

机构信息

Joy Dugan, Amy Butts, Billy St. John Collins, and Parmjeet S. Saini are members of the American Diabetes Association's Primary Care Advisory Group. Ms. Butts is an endocrinology PA for Wheeling Hospital in Wellsburg, W.Va. Dr. Collins is an associate clinical investigator in the cardiovascular branch of the National Heart, Lung & Blood Institute. Dr. Saini is a regulatory officer in the Northeast division of the survey and certification branch of the Centers for Medicare and Medicaid Services. Dr. Dugan is an associate program director at Touro University California Joint MSPAS/MPH Program. Sarah Bradley is director of professional engagement and collaborations for the American Diabetes Association in Arlington, Va. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2019 Aug;32(8):51-53. doi: 10.1097/01.JAA.0000569804.46658.ce.

DOI:10.1097/01.JAA.0000569804.46658.ce
PMID:31348103
Abstract

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality for patients with diabetes. The latest guidelines from the American Diabetes Association include new information on hypertension, lipid management, heart failure, and coronary heart disease. This year, for the first time, the cardiovascular disease and risk management section was endorsed by the American College of Cardiology. Primary and secondary prevention of ASCVD is a critical element of the primary care visit for patients with diabetes. This article provides key highlights that are important for busy clinicians.

摘要

动脉粥样硬化性心血管疾病(ASCVD)是糖尿病患者发病和死亡的主要原因。美国糖尿病协会的最新指南包含了有关高血压、血脂管理、心力衰竭和冠心病的新信息。今年,心血管疾病与风险管理部分首次获得美国心脏病学会的认可。ASCVD的一级和二级预防是糖尿病患者初级保健就诊的关键要素。本文提供了对忙碌的临床医生很重要的关键要点。

相似文献

1
Updated management for patients with cardiovascular disease and diabetes.心血管疾病和糖尿病患者的最新管理方法。
JAAPA. 2019 Aug;32(8):51-53. doi: 10.1097/01.JAA.0000569804.46658.ce.
2
(8) Cardiovascular disease and risk management.(8)心血管疾病与风险管理。
Diabetes Care. 2015 Jan;38 Suppl:S49-57. doi: 10.2337/dc15-S011.
3
Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia.糖尿病血脂异常综述:糖尿病血脂异常的当前概念与管理指南更新
Am J Med Sci. 2016 Apr;351(4):361-5. doi: 10.1016/j.amjms.2016.01.020. Epub 2016 Feb 2.
4
Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease.糖尿病和动脉粥样硬化性心血管疾病患者中指南推荐的风险降低策略的应用
Circulation. 2019 Aug 13;140(7):618-620. doi: 10.1161/CIRCULATIONAHA.119.041730. Epub 2019 Jun 7.
5
Cardiovascular risk management in diabetes in primary care.基层医疗中糖尿病的心血管风险管理
J Pak Med Assoc. 2015 Aug;65(8):907-8.
6
Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.2013年美国心脏病学会/美国心脏协会(ACC/AHA)胆固醇管理指南发布后两年内,美国一项大型医保计划中他汀类药物的起始使用模式
J Am Heart Assoc. 2017 May 4;6(5):e005205. doi: 10.1161/JAHA.116.005205.
7
Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.评估他汀类药物治疗对美国动脉粥样硬化性心血管疾病一级预防的潜在人群影响:基于人群的建模研究。
BMJ Open. 2017 Jan 24;7(1):e011684. doi: 10.1136/bmjopen-2016-011684.
8
Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.美国心脏病学会/美国心脏协会(ACC/AHA)胆固醇指南对几种美国社区卫生中心网络中糖尿病患者心血管疾病预防中他汀类药物未充分利用的影响。
J Am Heart Assoc. 2017 Jul 3;6(7):e005627. doi: 10.1161/JAHA.117.005627.
9
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.根据2013年美国心脏病学会/美国心脏协会胆固醇指南,非传统风险标志物在不符合他汀类药物治疗条件的个体中的应用价值。
Circulation. 2015 Sep 8;132(10):916-22. doi: 10.1161/CIRCULATIONAHA.115.016846. Epub 2015 Jul 29.
10
[Guidelines for the management of atherosclerotic diseases in diabetes mellitus].[糖尿病患者动脉粥样硬化性疾病管理指南]
Nihon Rinsho. 2006 Nov;64(11):2074-80.

引用本文的文献

1
The value of serum Sema4D level in reflecting the inflammatory state of acute ST-segment elevation myocardial infarction.血清Sema4D水平在反映急性ST段抬高型心肌梗死炎症状态中的价值
J Thorac Dis. 2023 Feb 28;15(2):627-634. doi: 10.21037/jtd-23-124.